Three in 10 Hispanics in USA not filling scripts

29 March 2009

Struggling to meet health care costs, 29% of Hispanic adults  in the USA said they had decided against filling a script for cost reasons,  according to a national poll conducted by the Consumer Reports National  Research Center. Survey respondents said that they also economised by  asking their doctor for free samples, skipping doses, taking smaller  doses, or sharing a prescription with someone else on the same medicine

Consumer Reports' poll demonstrates that the majority of Hispanic  consumers in the USA are struggling with health care costs. When asked  about how easy or difficult it is to afford healthcare, 66% responded  "difficult" or very difficult," including 88% of those without health  insurance. Three-quarters of consumers earning under $50,000 and those  born outside the USA or Puerto Rico reported difficulty dealing with  cost, along with nearly seven in 10 of those under the age of 55.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight